Latest Update A-Rod paid cousin nearly $1 million to keep quiet Tue Nov, 04, 09:56 AM
Is one of the best sluggers and run-producers of all time, and owns prodigious home-run power. Still owns a great arm at the hot corner. Is a good base-runner who can steal a base.
Flaws: : His defense has declined over the years. Hasn't always performed to the best of his abilities under the spotlight (and in the clutch). Controversy has dogged him throughout his career.
Oh boy. Here we go again. Even after serving his suspension, Rodriguez continues to be bashed in the media for his role in the Biogenesis scandal and his actions regarding PEDs use. So he tried to buy his cousin's silence here. Is that such a big deal anymore? Melky Cabrera and his people faked an entire web site to try and get around his suspension and the general public seems to have forgiven him for the most part. We'd all like to move past this, but it appears that Rodriguez will continue to be publicly vilified while the rest of the offenders are allowed to move on with their lives and careers.Analyst: Howard Bender
Rodriguez was suspended for the entire 2014 season for violating the leagues performance enhancing drug policy. His reinstatement to the Yankees is big news in baseball as their had been some contention between ARod and the Yankees last season and during his suspension. Analyst: Jonathan Impemba
The return of Alex Rodriguez will dominate the media as the 2015 season begins. ARod could find himself with some increased fantasy value if he can stay healthy given his home ballpark and the possible addition of first base eligibility.Analyst: Jonathan Impemba
Probably not the news Yankees fans want to here as they not only miss the playoffs, but they also say goodbye to Derek Jeter after 20 years of service. But nevertheless, A-Rod will be back, for better or for worse, and given the state of third base in fantasy leagues right now, he could prove to be one of the top guys at the position if he can find his power stroke without performance-enhancing drugs.Analyst: Howard Bender